Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1Other 1

Conditions

Prostatic Neoplasms 9Lung Neoplasms 9Breast Neoplasms 8Colorectal Neoplasms 6Hematopoietic and Lymphatic System Neoplasm 4Hematologic Neoplasms 2Fatigue 2Chronic Pain 2Carcinoma, Non-Small-Cell Lung 2Advanced Malignant Solid Neoplasm 2Venous Thrombosis 1Venous Thromboembolism 1Uterine Cervical Neoplasms 1Triple Negative Breast Neoplasms 1Syndrome 1Sunburn 1Spondylitis, Ankylosing 1Skin Neoplasms 1Sarcoma 1Pulmonary Embolism 1Psoriasis 1Overweight 1Ovarian Neoplasms 1Obesity-Related Malignant Neoplasm 1Obesity 1Neoplastic Syndromes, Hereditary 1Neoplasms 1Neoplasm Metastasis 1Melanoma 1Malignant Solid Neoplasm 1

Interventions

Standard of Care 1Spinal Cord Stimulation 1Specimen Handling 1Practice Guidelines as Topic 1Methods 1Massage 1Interviews as Topic 1Educational Status 1Early Intervention, Educational 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Chemotherapy-Induced Peripheral Neuropathy × Educational Status × Clear all
NCT07365007 2026-03-03

A Virtually Delivered Diet Intervention (LASO-3) for the Improvement of Chemotherapy-Induced Peripheral Neuropathy in Cancer Survivors Post-treatment

University of Michigan Rogel Cancer Center

Phase NA Recruiting
50 enrolled
OtherOther solid neoplasm

Chemotherapy-Induced Peripheral Neuropathy

Data powered by HemOnc (CC BY 4.0) Colophon âš¡